Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of once-daily O304 on fasting plasma glucose in type 2 diabetes (TELLUS)
2016-002183-13Phase 2Completed
- Sponsor
- Betagenon
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ATX304 in type 2 diabetes mellitus (T2DM), sponsored by Betagenon. Started Jul 2016; status: completed.
02
Drugs
ATX304
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2016-002183-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002183-13.